Literature DB >> 20961665

Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome.

Andrea Schneider1, Elizabeth Ballinger, Alyssa Chavez, Flora Tassone, Randi J Hagerman, David Hessl.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late onset neurodegenerative disorder that affects carriers of the fragile X premutation, typically after age 50. Common symptoms include intention tremor, ataxia, neuropathy, autonomic dysfunction, cognitive decline, and dementia. The objectives of this study were to determine if patients with FXTAS have altered prepulse inhibition (PPI; a measure of sensorimotor gating), and to study possible correlations between PPI, molecular status, and cognitive performance. A passive acoustic PPI paradigm was applied in 163 subjects; 121 carriers of the fragile X premutation, and 42 healthy controls. There were significant differences in PPI between premutation carriers with FXTAS and controls at PPI 60 ms, and at 120 ms. This effect was more prominent in the male FXTAS patients. There was a tendency to an impaired PPI in female premutation carriers at the 120 ms condition. There was a significant correlation between the PPI deficit and a higher CGG repeat number. The results show an impairment in sensorimotor gating processes in male carriers of the fragile X premutation, which is more prominent in patients with FXTAS.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961665      PMCID: PMC3044775          DOI: 10.1016/j.neurobiolaging.2010.09.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  55 in total

Review 1.  Assessing prepulse inhibition of startle in wild-type and knockout mice.

Authors:  M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

2.  Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication.

Authors:  V Kumari; W Soni; V M Mathew; T Sharma
Journal:  Arch Gen Psychiatry       Date:  2000-06

3.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.

Authors:  R J Hagerman; M Leehey; W Heinrichs; F Tassone; R Wilson; J Hills; J Grigsby; B Gage; P J Hagerman
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

Review 4.  Mouse genetic models for prepulse inhibition: an early review.

Authors:  M A Geyer; K L McIlwain; R Paylor
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

5.  Standardization of a neuromotor test battery: the CATSYS system.

Authors:  C Després; D Lamoureux; A Beuter
Journal:  Neurotoxicology       Date:  2000-10       Impact factor: 4.294

Review 6.  Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges.

Authors:  N R Swerdlow; M A Geyer; D L Braff
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 7.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

8.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen Leehey; Jim Grigsby; Lin Zhang; James A Brunberg; Claudia Greco; Vincent Des Portes; Tristan Jardini; Richard Levine; Elizabeth Berry-Kravis; W Ted Brown; Stephane Schaeffer; John Kissel; Flora Tassone; Paul J Hagerman
Journal:  Am J Hum Genet       Date:  2003-03-12       Impact factor: 11.025

9.  Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia.

Authors:  Erica J Duncan; Sandor Szilagyi; Toby R Efferen; Marion P Schwartz; Arti Parwani; Subhajit Chakravorty; Steven H Madonick; Alena Kunzova; James W Harmon; Burt Angrist; Stephen Gonzenbach; John P Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  2003-03-11       Impact factor: 4.530

10.  A quantitative assessment of tremor and ataxia in FMR1 premutation carriers using CATSYS.

Authors:  Dalila Aguilar; Kathryn E Sigford; Kultida Soontarapornchai; Danh V Nguyen; Patrick E Adams; Jennifer M Yuhas; Flora Tassone; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-03-01       Impact factor: 2.802

View more
  13 in total

1.  New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS).

Authors:  Jorge L Juncos; Joash T Lazarus; Emily Graves-Allen; Lisa Shubeck; Michelle Rusin; Gloria Novak; Deborah Hamilton; Julia Rohr; Stephanie L Sherman
Journal:  Neurogenetics       Date:  2011-01-29       Impact factor: 2.660

Review 2.  What has been learned from mouse models of the Fragile X Premutation and Fragile X-associated tremor/ataxia syndrome?

Authors:  Molly M Foote; Milo Careaga; Robert F Berman
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

Review 3.  Fragile X-associated tremor/ataxia syndrome.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Ann N Y Acad Sci       Date:  2015-01-26       Impact factor: 5.691

4.  Impaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model mice.

Authors:  A J Renoux; K J Sala-Hamrick; N M Carducci; M Frazer; K E Halsey; M A Sutton; D F Dolan; G G Murphy; P K Todd
Journal:  Behav Brain Res       Date:  2014-03-19       Impact factor: 3.332

Review 5.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

Review 6.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice.

Authors:  Molly Foote; Gloria Arque; Robert F Berman; Mónica Santos
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

Review 7.  Understanding the neuropsychiatric phenotype of fragile X-associated tremor ataxia syndrome: a systematic review.

Authors:  R C Birch; K M Cornish; D R Hocking; J N Trollor
Journal:  Neuropsychol Rev       Date:  2014-05-15       Impact factor: 7.444

Review 8.  Auditory processing in fragile x syndrome.

Authors:  Sarah E Rotschafer; Khaleel A Razak
Journal:  Front Cell Neurosci       Date:  2014-02-04       Impact factor: 5.505

Review 9.  Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the field.

Authors:  Michael R Hunsaker
Journal:  F1000Res       Date:  2013-12-27

10.  Expression of an expanded CGG-repeat RNA in a single pair of primary sensory neurons impairs olfactory adaptation in Caenorhabditis elegans.

Authors:  Bi-Tzen Juang; Anna L Ludwig; Kelli L Benedetti; Chen Gu; Kimberly Collins; Christopher Morales; Aarati Asundi; Torsten Wittmann; Noelle L'Etoile; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-05-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.